Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib.
Serova M, Tijeras-Raballand A, Dos Santos C, Martinet M, Neuzillet C, Lopez A, Mitchell DC, Bryan BA, Gapihan G, Janin A, Bousquet G, Riveiro ME, Bieche I, Faivre S, Raymond E, de Gramont A. Serova M, et al. Among authors: de gramont a. Oncotarget. 2016 Jun 21;7(25):38467-86. doi: 10.18632/oncotarget.9542. Oncotarget. 2016. PMID: 27509260 Free PMC article.
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients.
Serova M, Tijeras-Raballand A, Dos Santos C, Albuquerque M, Paradis V, Neuzillet C, Benhadji KA, Raymond E, Faivre S, de Gramont A. Serova M, et al. Among authors: de gramont a. Oncotarget. 2015 Aug 28;6(25):21614-27. doi: 10.18632/oncotarget.4308. Oncotarget. 2015. PMID: 26057634 Free PMC article.
Targeting cancer cell metabolism in pancreatic adenocarcinoma.
Cohen R, Neuzillet C, Tijeras-Raballand A, Faivre S, de Gramont A, Raymond E. Cohen R, et al. Among authors: de gramont a. Oncotarget. 2015 Jul 10;6(19):16832-47. doi: 10.18632/oncotarget.4160. Oncotarget. 2015. PMID: 26164081 Free PMC article. Review.
Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib.
Serova M, de Gramont A, Tijeras-Raballand A, Dos Santos C, Riveiro ME, Slimane K, Faivre S, Raymond E. Serova M, et al. Among authors: de gramont a. Cancer Chemother Pharmacol. 2013 May;71(5):1297-307. doi: 10.1007/s00280-013-2129-6. Epub 2013 Mar 12. Cancer Chemother Pharmacol. 2013. PMID: 23479136
Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas.
Neuzillet C, de Gramont A, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S, Raymond E. Neuzillet C, et al. Among authors: de mestier l, de gramont a. Oncotarget. 2014 Jan 15;5(1):78-94. doi: 10.18632/oncotarget.1569. Oncotarget. 2014. PMID: 24393789 Free PMC article. Review.
Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue.
Albert S, Hourseau M, Halimi C, Serova M, Descatoire V, Barry B, Couvelard A, Riveiro ME, Tijeras-Raballand A, de Gramont A, Raymond E, Faivre S. Albert S, et al. Among authors: de gramont a. Oral Oncol. 2012 Dec;48(12):1263-71. doi: 10.1016/j.oraloncology.2012.06.010. Epub 2012 Jul 7. Oral Oncol. 2012. PMID: 22776129
OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis.
Astorgues-Xerri L, Riveiro ME, Tijeras-Raballand A, Serova M, Rabinovich GA, Bieche I, Vidaud M, de Gramont A, Martinet M, Cvitkovic E, Faivre S, Raymond E. Astorgues-Xerri L, et al. Among authors: de gramont a. Eur J Cancer. 2014 Sep;50(14):2463-77. doi: 10.1016/j.ejca.2014.06.015. Epub 2014 Jul 16. Eur J Cancer. 2014. PMID: 25042151
398 results